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Abstract
Background: To investigate ethnic differences in vitamin D levels during pregnancy, assess risk factors for vitamin
D deficiency and explore the effect of vitamin D supplementation in women with deficiency in early pregnancy.
Methods: This is a population-based, multiethnic cohort study of pregnant women attending Child Health Clinics
for antenatal care in Oslo, Norway. Serum-25-hydroxyvitamin D [25(OH)D] was measured in 748 pregnant women
(59 % ethnic minorities) at gestational weeks (GW) 15 (SD:3.6) and 28 (1.4). Women with 25(OH)D <37 nmol/L at
GW 15 were for ethical reasons recommended vitamin D3 supplementation. Main outcome measure was 25(OH)D,
and linear regression models were performed.
Results: Severe deficiency (25(OH)D <25 nmol/L) was found at GW 15 in 45 % of women from South Asia, 40 %
from the Middle East and 26 % from Sub-Saharan Africa, compared to 2.5 % in women from East Asia and 1.3 %
of women from Western Europe. Women from South Asia, the Middle East and Sub-Saharan Africa had mean
values that were −28 (95 % CI:-33, −23), −24 (−29, −18) and −20 (−27, −13) nmol/L lower than in Western women,
respectively. Ethnicity, education, season and intake of vitamin D were independently associated with 25(OH)D.
At GW 28, the mean 25(OH)D had increased from 23 (SD:7.8) to 47 (27) nmol/L (p < 0.01) in women who were
recommended vitamin D supplementation, with small or no change in women with sufficient vitamin D levels
at baseline.
Conclusions: Vitamin D deficiency was prevalent among South Asian, Middle Eastern and African women. The
serum levels of 25(OH)D increased significantly from GW 15 to 28 in vitamin D deficient women who received a
recommendation for supplementation. This recommendation of vitamin D supplementation increased vitamin D
levels in deficient women.
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Background
Vitamin D deficiency in pregnancy is prevalent [1], espe-
cially in women with limited access to sunlight due to
minimal outdoor activity or heavy use of sunscreen,
cultural practices or traditional clothing, and among
women with dark skin pigmentation. In Europe, vitamin
D deficiency is reported to be prevalent among pregnant
ethnic minority women in the Netherlands [2] and UK
[3], but is also observed in the majority population
[3–5]. Little is known about the prevalence of vitamin D
deficiency among Asian and African pregnant women liv-
ing in Northern Europe, although a few small studies from
Sweden [6, 7] and Norway [8] report a high prevalence of
vitamin D deficiency among Somali and Pakistani women.
There are few population-based studies exploring vitamin
D deficiency in pregnancy in today’s multiethnic Europe,
and little is known about the impact of socioeconomic
status or the effect of vitamin D supplements [9, 10]. Also
studies of multiethnic populations in Australia have
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uncovered maternal country of birth in Asia and Africa as
risk factor of vitamin D deficiency in pregnancy [11].
Studies provide inconsistent and conflicting evidence
for adverse maternal and child health outcomes related
to vitamin D deficiency [11–16]. However, the current
state of evidence suggests unclear benefits of routine
vitamin D supplementation for most maternal or child
health outcomes [17]. Most studies report results from
interventions in non-deficient women. Despite the con-
troversies related to adverse outcomes, and lack of
evidence of clear benefits of routine supplementation,
most Western countries recommend vitamin D supple-
mentation during pregnancy.
The aims of this paper were to investigate ethnic dif-
ferences in vitamin D levels during pregnancy, assess
risk factors for vitamin D deficiency and explore the
effect of vitamin D supplementation in women identified
with low values during early pregnancy.
Methods
Design, setting and study population
Data are from the STORK Groruddalen project, which is
a population-based, prospective cohort of 823 healthy
women from 65 countries attending Child Health Clinics
(CHC) for antenatal care in Groruddalen, Oslo, Norway,
between May 2008 and March 2010. Groruddalen covers
affluent as well as relatively economically deprived resi-
dential areas, and has a population with diverse socio-
economic status. This area was selected to ensure a high
proportion of women with an ethnic minority back-
ground, and because the majority (75-85 %) of pregnant
women residing in this area attend the Child Health
Clinics for antenatal care. Antenatal care is free of
charge in Norway and easily accessible. To facilitate
inclusion of ethnic minority women, information mater-
ial about the study and questionnaires were translated to
Arabic, English, Sorani, Somali, Tamil, Turkish, Urdu and
Vietnamese and quality checked by bilingual health pro-
fessionals. The STORK Groruddalen project has been
described in detail elsewhere [18]. In short, women were
eligible if they 1) lived in the district, 2) planned to give
birth at one of the two study hospitals, 3) were <20 weeks
pregnant, 4) could communicate in Norwegian or any of
the specified languages and 5) were able to provide written
consent to participate. Women with pre-pregnancy dia-
betes or other diseases necessitating intensive hospital
follow-up during pregnancy were excluded. In total, 59 %
of the included women were of ethnic minority back-
ground. The participation rate was 74 % (range: 64-83 %
for ethnic groups), and the participating women were
found representative for the main ethnic groups of preg-
nant women attending Child Health Clinics in Oslo [18].
Data from questionnaires, measurements and blood sam-
ples were collected at 15 and 28 weeks of gestation,
through interviews by specially trained and certified
midwives according to the study protocol, assisted by
professional interpreters when needed.
Data collection and variables
Primary outcome measure
S-25-hydroxyvitamin D [25(OH)D] was analyzed by com-
petitive radioimmunoassay (DiaSorin, Stillwater, MN,
USA) at the Hormone Laboratory, Oslo University
Hospital, Aker. The method measures a total value of
25(OH)D (both 25(OH)D2 and -D3), with intra- and inter-
assay coefficients of variation 6 % and 13-16 %,
respectively. The laboratory’s normal reference range
was 37–131 nmol/l based on the ethnic Norwegian
population from the Oslo Health Study [19]. The
laboratory is accredited by International Organization
for Standardization and is part of the Vitamin D
Quality Assessment Scheme, DEQAS. Samples were
analyzed consecutively and results were sent to the
participant’s midwife.
In this paper, vitamin D deficiency was defined as
25(OH) D <50 nmol/L, and severe vitamin D deficiency
was defined as 25(OH) D <25 nmol/L, in accordance
with relevant literature [20]. Undetectable concentra-
tions of 25(OH)D (<12 nmol/L) were replaced with
“11 nmol/L” in the calculations (n = 17).
Explanatory factors
Ethnic origin was defined by the participant’s mother’s
country of birth[18]. Ethnicity was further categorized
into Western Europe (primarily Norway, Sweden and
Denmark), South Asia (primarily Pakistan and Sri
Lanka), Middle East (primarily Iraq, Turkey, Morocco
and Afghanistan), Africa (Somalian being the largest
group), East Asia (primarily Vietnam, Philippines and
Thailand), and Other (primarily Poland, Russia and
Kosovo). Parity was categorized as no children (nullipar-
ous), one child (uniparous) and two or more children
(multiparous). Pre-pregnancy body mass index (BMI;
calculated from self-reported weight before pregnancy and
height measured at inclusion) was categorized as
<25 kg/m2 and ≥25 kg/m2. Education level was cate-
gorized as <10 years, 10–12 years and >12 years.
Winter season was defined as December to May. Ac-
cording to National Clinical Guidelines for Antenatal
Care, the recommendation of vitamin D intake during
a normal pregnancy is 10 μg/day [21]. All participants
were asked about their intake of vitamin D supplements
including prenatal vitamins during the past two weeks at
both visits, and self-reported intake was categorized as “
vitamin D ≥10 μg/day” and “no or vitamin D <10 μg/day”.
Other variables of interest were age and gestational week
at inclusion. Gestational week at inclusion was dichoto-
mized according to the median.
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The recommendation of vitamin D supplementation
Pre-planned, and according to the protocol, women with
25(OH)D less than the laboratory’s lower reference range
(<37 nmol/L) at gestational week 15 were provided with
written information describing their 25(OH)D D con-
centration, and they were recommended to consult their
General Practitioner (GP) for treatment. Specially, these
women were provided a written note advising their GP
to prescribe 20 μg (800 IU)/day vitamin D3 for 1–3
months if 25(OH)D ranged from 12–37 nmol/L or 30 μg
(1200 IU)/day vitamin D3 for 3 months if 25(OH)D
<12 nmol/L. In addition, 1 g calcium/day was recom-
mended for both groups, and GPs were encouraged to
offer follow-up measurements. Due to lack of safety
evidence for the fetus and mother for higher doses, and
to avoid hypercalcemia in the fetus/newborn, we used
a daily dose below the Tolerable Upper Intake Level
(for adults 50 μg/d (2000 IU)) when the study was
performed [22]. We have no information on the exact
dose of vitamin D supplements taken if self-reported
intake was >10 μg/day.
Ethics
The Regional Committee for Medical and Health Research
Ethics South East (Ref 2007/894) and the Norwegian Data
Inspectorate approved the study protocol. Participation
was based on informed, written consent.
Study sample
Of the 823 women included in the STORK Groruddalen
project, 807 (98 %) had 25(OH)D concentrations mea-
sured at gestational week 15. At gestational week 28, 20
women had had an abortion or extreme premature deliv-
ery, 29 did not re-attend, and 10 women lacked a 25(OH)
D value, resulting in a final sample of 748 (91 %) women
with two 25(OH)D measurements in this study (Flow
chart, Additional file 1: Supplementary Figure).
Statistics
Descriptive statistics are presented as frequencies, pro-
portions, mean values and standard deviations (SD). All
continuous variables were assessed for normality. In
Additional file 2: Supplementary table, we report mean
values for 25(OH)D for ethnic groups with ≥10 partici-
pants. Comparisons of means and proportions were
tested by independent and paired t-tests and chi-square
tests. Explanatory linear regression models were per-
formed to assess the relationship between ethnicity and
the concentration of 25(OH)D, both at inclusion and in
gestational week 28, accounting for the following potential
confounding factors: gestational week, age, parity, season,
education, vitamin D supplements and pre-pregnancy
BMI. Due to a non-linear relation with 25(OH)D,
pre-pregnancy BMI was dichotomized. Factors with a
p-value <0.2 in the univariate analysis were included
in the multiple regression analyses. Interactions were
examined graphically and by adding interaction terms
(Western and summer vs non-Western and winter)
into the models. Results are presented as regression
coefficients (B) with 95 % confidence intervals (CI)
and accompanied adjusted R2. P-values <0.05 were
considered statistically significant. SPSS software (Ver-
sion 22, IBM SPSS statistics, NY, USA) was used for
statistical analysis.
Results
Mean maternal age was 30 (SD: 4.9) years (range 19 to
45) and mean pre-pregnancy BMI 24.6 (SD: 4.8) kg/m2.
The mean gestational week was 15.4 (SD: 3.6) at inclu-
sion and 28.8 (1.4) at the follow-up visit (Table 1). The
ethnic minority women were younger, had higher parity
and lower education (25 % reported no, or less than
10 years of schooling) than Western European women.
A total of 23 % of ethnic minority women needed an in-
terpreter (21 % reported “poor" or “somewhat poor”
skills in the Norwegian language, while 18 % “medium”
skills). Reported reasons for migrating to Norway were
work or studies (9.1 %), refugees or asylum seekers
(18 %) and family immigration (73 %). About two
thirds of Western European and East Asian women
reported using vitamin D supplements regularly at in-
clusion compared to 50 % of other ethnic groups.
At gestational week 28, the proportion of South Asian
and Middle Eastern women who had used vitamin D
supplements ≥10 μg/day over the past two weeks was
higher than at gestational week 15 (p < 0.01 and p < 0.05,
respectively). No change in the proportion using
vitamin D supplements was observed among the other
ethnic groups (Table 1). No significant differences be-
tween the study sample and the 75 excluded women were
found for ethnicity, age, gestational week (both visits), par-
ity, pre-pregnant BMI and education (data not shown).
Vitamin D status in early pregnancy at gestational
week 15
The 25(OH)D concentration at inclusion ranged from <12
to 148 nmol/L, with large differences in mean values
between the ethnic groups (Table 2). Mean values for
countries with ≥10 participants are provided in
Additional file 2: Supplementary table. The preva-
lence of 25(OH)D <50 nmol/L differed between the
ethnic groups as follows: South Asia: 84 %, the
Middle East: 79 %, Sub-Saharan Africa: 75 %, East
Asia: 43 % and Western Europe: 20 %. For severe
deficiency (25(OH)D <25 nmol/L), corresponding
numbers were: South Asia: 45 %, the Middle East:
40 %, Sub-Saharan Africa: 26 %, East Asia: 2.5 % and
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Western Europe: 1.3 %, representing 20 % of the
total cohort (Fig. 1).
In early pregnancy, the values of 25(OH)D differed be-
tween the ethnic groups and remained significant after
adjustment for age, parity, season, education and intake
of vitamin D supplements (Table 3). Women from South
Asia, the Middle East and Sub-Saharan Africa had mean
values that were −28 (95 % CI: −33, −23), −24 (−29, −18)
and −20 (−27, −13) nmol/L lower than in Western
European women, respectively. In addition, education,
intake of vitamin D supplements and season were in-
dependently associated with 25(OH)D concentrations
at inclusion. The effect of season on 25(OH)D differed
by ethnicity (interaction term, p < 0.01). Western
European women had a higher concentration of
25(OH)D during summer compared to winter, while
no seasonal difference was observed among ethnic
minority women, and their mean values were lower
than Western Europeans.
Vitamin D status at gestational week 28
At the beginning of the third trimester, the prevalence of
25(OH)D <50 nmol/L among the largest ethnic minority
groups was lower than at study inclusion: South Asia:
62 %, the Middle East: 58 % and Sub-Saharan Africa:
63 %. The prevalence of 25(OH)D <25 nmol/L was also
lower: South Asia: 17 %, Middle East: 15 %, Sub-Saharan
Africa: 20 % (Fig. 1).
Mean 25(OH)D values were −17 (95 % CI: −23, −11),
−10 (−16, −2.9) and −12 (−20, −3.1) nmol/L lower in
Table 1 Characteristics of the total cohort of pregnant women at inclusion and at gestational week 28 stratified by geographic
region. Numbers are frequencies (%) and means (SD)
Total Western Europea South Asia Middle East Sub-Saharan Africa East Asia Other
n = 748 n = 304 n = 189 n = 113 n = 51 n = 40 n = 51
100 % 41 % 25 % 15 % 6.8 % 5.3 % 6.8 %
Pre-pregnancy maternal status
Years of maternal age; mean (SD) 29.9 (4.9) 30.9 (4.5) 28.7 (4.5) 29.6 (5.5) 28.1 (5.2) 31.1 (4.5) 29.3 (5.1)
Parity; n (%)
Para 0 340 (46) 156 (51) 78 (41) 39 (35) 22 (43) 17 (42) 28 (55)
Para 1 259 (34) 113 (37) 63 (33) 39 (35) 11 (22) 16 (40) 17 (33)
Para ≥2 149 (20) 35 (12) 48 (25) 35 (30) 18 (35) 7 (18) 6 (12)
Education level; n (%)b
<10 years 119 (16) 10 (3.3) 33 (18) 41 (36) 22 (43) 8 (20) 5 (9.8)
10-12 years 296 (40) 93 (30) 95 (50) 51 (45) 22 (43) 16 (40) 19 (37)
>12 years 327 (44) 199 (66) 60 (32) 19 (17) 7 (14) 16 (40) 26 (51)
Pre-pregnancy BMIb (kg/m2); mean (SD) 24.6 (4.8) 24.6 (4.8) 23.7 (4.1) 25.8 (5.0) 26.1 (6.1) 22.2 (3.4) 24.9 (5.4)
Status at inclusion
Gestational week; mean (SD) 15.4 (3.6) 14.5 (2.4) 15.9 (4.1) 15.6 (3.3) 17.9 (5.4) 16.4 (4.3) 15.5 (3.4)
Season of blood sample; n (%)
Winter 395 (53) 158 (52) 92 (49) 70 (62) 32 (63) 22 (55) 21 (41)
Vitamin D supplements; n (%)b
No or <10 μg daily past two weeks 307 (41) 104 (34) 93 (49) 55 (49) 25 (49) 12 (30) 18 (35)
Status at gestational week 28
Gestational week; mean (SD) 28.8 (1.4) 28.7 (1.3) 28.7 (1.4) 29.0 (1.6) 29.0 (1.5) 28.7 (1.2) 29.0 (1.7)
Weight gain (week 28 minus 15); mean (SD) 6.6 (3.2) 6.7 (2.7) 6.5 (3.3) 6.7 (3.6) 4.6 (3.0) 6.2 (2.5) 8.0 (3.9)
Season of blood sample; n (%)
Winter 410 (55) 178 (59) 97 (51) 65 (57) 28 (55) 17 (57) 25 (49)
Vitamin D supplements; n (%)b
No or <10 μg daily past two weeks 243 (33) 115 (38) 41 (22) 37 (33) 20 (40) 14 (35) 16 (31)
Notes:
Countries with ≥10 individuals are listed: 304 women from Western Europe, primarily from Norway (n = 278), 189 women from South Asia, primarily from Pakistan
n = 120), Sri Lanka (n = 56) and India (n = 12), 113 women from the Middel East, primarily from Iraq (n = 34), Morocco (n = 27), Turkey (n = 25), Afghanistan (n = 12),
51 women from Sub-Saharan Africa, primarily from Somalia (n = 32), 40 women from East Asia, primarily Vietnam (n = 17), Philippines (n = 12).
aIncluding 3 women from USA and Canada
bIncomplete data on the variables because of missing values for 6–12 women
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South Asians, Middle Easterners and Sub-Saharan
Africans compared with Western Europeans after adjust-
ments for gestational week at inclusion, age, parity, season,
education and vitamin D supplements (Table 3). In
addition, age, parity, education, intake of vitamin D sup-
plementation and gestational week at inclusion were inde-
pendently associated with 25(OH)D concentrations. The
effect of season on 25(OH)D differed by ethnicity (inter-
action term, p < 0.01) at gestational week 28.
A sensitivity analysis to evaluate the effect of the inter-
action term was performed. When excluding the geo-
graphic region*season interaction term from the
multiple analyses (Table 3), the coefficients for ethnic
minority groups and season were reduced by the same
amount as the interaction-coefficient, while the coeffi-
cients for the remaining factors were about the same.
Vitamin D status in women who were recommended
supplementation in early pregnancy
In total, 258 women (35 %) had values <37 nmol/L at
inclusion and were recommended to consult their GPs for
supplements. Only 37 % of these women reported an
intake of ≥10 μg/day of vitamin D supplements, but
at gestational week 28, this proportion had increased
to 73 % (p < 0.01). Among the 67 women reporting
no or <10 μg/day at this time point, 11 women had
25(OH)D >50 nmol/L and 26 women (10 % of the
group recommended supplementation and 3.5 % of
the total cohort), had 25(OH)D <25 nmol/L. In paral-
lel to the increased use of supplements in this group,
the mean 25(OH)D increased from 23 (SD:7.8) to 47
(27) nmol/L (p < 0.01). No changes in mean 25(OH)D
were observed among women with baseline values
>50 nmol/L, while a slight increase in mean 25(OH)D was
observed in women with baseline values ranging from 37–
50 nmol/L. Corresponding results are presented for
Western European women (Fig. 2a) and the merged ethnic
minority groups (Fig. 2b). The mean change in 25(OH)D
from GW 15 to 28 was 24 nmol/L in the group recom-
mended supplementation compared to 0.1 nmol/L in the
group with levels ≥37 nmol/L (p < 0.01).
Discussion
Main findings
In this cohort study we found a high prevalence of vita-
min D deficiency (<50 nmol/L) in early pregnancy
among women from South Asia, Middle East and Sub-
Saharan Africa, and severe deficiency (<25 nmol/L) was
prevalent among women from these regions. Independ-
ent risk factors for low 25(OH)D values in early preg-
nancy included ethnic origin from South Asia, the
Middle East and Sub-Saharan Africa, low intake of sup-
plements, low education, and examination during winter.
Among women who were recommended to consult their
GPs for supplementation, use of supplements and levels
of 25(OH)D increased substantially more than in women
with values ≥37 nmol/L who not were exposed to this
recommendation.
Strengths and limitations
The major strength of the study is that we followed a
large number of healthy women representative for the
main ethnic groups of pregnant women in Oslo through
pregnancy. The questionnaires were translated to eight
languages and data collection methods were adapted to
facilitate inclusion of ethnic minorities and even illiterate
women, who are often excluded in research [18]. Profes-
sional interpreters were used to ensure the quality of the
Table 2 Descriptive vitamin D at inclusion (gestational week 15)
and at gestational week 28. Crude mean (SD) Vitamin D
[25(OH)D in nmol/l] levels according to potential explanatory
factors
At inclusion At gestational week 28
n = 748 n = 748
Mean (SD) Mean (SD)
Overall mean 25(OH)D 50 (27) 59 (29)
Age at inclusion
≤30 years 47 (25) 55 (27)
>30 years 54 (28) 62 (30)
Parity (Para 0 ref) 53 (26) 61 (29)
Para 1 52 (28) 59 (27)
Para ≥2 42 (25) 52 (30)
Western Europe (ref) 69 (24) 72 (28)
South Asia 32 (19) 46 (23)
Middle East 34 (20) 51 (29)
Sub-Saharan Africa 38 (18) 45 (25)
East Asia 51 (17) 53 (19)
Other 56 (21) 63 (26)
Season of blood sample
Summer 56 (29) 60 (29)
Winter 46 (24) 57 (27)
Education level (>12 years ref) 60 (27) 67 (27)
10-12 years 46 (25) 56 (29)
<10 years 37 (20) 44 (23)
Vitamin D supplements
≥10 μga 57 (26) 61 (28)
No or <10 μg 42 (26) 53 (29)
Pre-pregnancy BMI; kg/m2
(normal weight (<25) ref)
51 (27) 59 (29)
Overweight (≥25/<30) 51 (27) 61 (31)
Obesity (≥30) 48 (24) 54 (24)
aIntake of ≥10 μg vitamin D daily past two weeks
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interview administered questionnaire data. We were able
to include a relatively wide range of explanatory factors,
and we collected data at two time points in pregnancy.
The blood samples were analyzed at the same laboratory
with standardized methods.
However, there are also weaknesses. This was not a
randomized, controlled trial, but was evaluated by a pre-
post test design. We do not directly know the impact of
the letter from the study personnel to the GPs, nor do
we know the participants’ level of adherence to the rec-
ommendations from the GPs. However, 73 % reported
use of ≥10 μg/day of vitamin D supplements at the post-
test, and only 3.5 % still had severe deficiency, compared
to 20 % at inclusion. We lack information on other vari-
ables affecting the concentration of 25(OH)D, including
the degree of concealing clothes, skin pigmentation and
sunlight exposure.
Interpretation
Our findings are in line with others confirming wide-
spread vitamin D deficiency during pregnancy among
ethnic minorities [2, 3, 11, 23, 24], although some stud-
ies from Northern Europe have found a comparatively
higher prevalence and more severe deficiency than ob-
served in our study [6, 25]. Recent studies from the same
part of Oslo may have increased awareness of vitamin D
deficiency among health personnel [26–28], which may
have contributed to the somewhat lower prevalence of
vitamin D deficiency in ethnic minorities in our study.
However, direct comparison of 25(OH)D values between
studies are hampered by different methodologies such as
inconsistent definitions of vitamin D deficiency, labora-
tory measurements and degree of adjustment for
possible confounders.
Most studies that we identified were cross-sectional,
and few adjusted for intake of vitamin D supplements,
education, parity and seasonal variance [5, 29]. At high
latitude, seasonal variance is an important explanatory
factor, as the sun is not capable of producing vitamin D
by skin radiation during winter time [30]. Some ethnic
minority groups have other traditions of sun exposure
than Western European women. However, we did not
identify other studies from Europe testing for the inter-
action of ethnicity and season, while no interaction was
found in a study from the US [31]. We found that low
education was an independent risk factor for low values
of 25(OH)D, but did not identify other studies from
Europe which investigated education as an explanatory
factor, although one study from the Netherlands found
that less educated women had lower 25(OH)D levels
compared to high educated women[32]. Our data also
indicated that low self-reported intake of vitamin D sup-
plements was an independent risk factor for vitamin D
deficiency, also found in an Irish study [3]. In contrast to
several prior studies, BMI was not a significant risk
factor in our sample [5, 11, 33].
The debate about the optimal dose of vitamin D sup-
plementation during pregnancy is ongoing. Guidelines
from Scandinavia and UK recommend all pregnant
women supplement intake with 10 μg (400 IU) vitamin
D daily to prevent vitamin D deficiency [21, 34, 35]. The
guidelines from the Institute of Medicine (IOM)[36], the
Endocrine Society Clinical Practice [37], the WHO [38]
and the Canadian Pediatric Society [39] differ. There is
no consensus of the optimal concentration of 25(OH)D
in pregnancy [40, 41]. There is no doubt that low infant
25(OH)D increases the risk of skeletal diseases such as
rickets and hypocalcemia, but the effect of maternal
deficiency on the fetus is not clear. Concerns about the
Fig. 1 Proportions of participants with levels of 25(OH)D 12- < 25 nmol/L and <12 nmol/L at gestational week 15 and 28
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impact of low 25(OH)D concentrations during preg-
nancy on fetal development is present, as low levels
have been associated with preterm birth, low birth
weight, bone mass and postnatal calcium concentra-
tions, as well as preeclampsia and gestational diabetes
in the mother [11, 42].
Several studies among pregnant women have
showed a marked increase in 25(OH)D with daily
supplements of vitamin D [11, 24, 43, 44]. Although
there may be changes to the pharmacokinetics of
25(OH)D during pregnancy, such as increased bind-
ing proteins and fluid redistribution, most studies re-
port that 25(OH)D concentration is relatively
constant, at least during the first two trimesters [4,
45]. However, some evidence suggests vitamin D
binding protein may increase and the free fraction of
25(OH)D may decrease [46, 47].
In women who were recommended daily vitamin D
supplements of 20 μg or 30 μg due to low values in early
pregnancy, we observed an increase in self-reported use
of supplements at the follow-up visit. We similarly ob-
served a substantial increase in 25(OH)D concentrations
and a reduced prevalence of 25(OH)D <25 nmol/L. The
small increase of 25(OH)D observed among women with
a slight deficiency at baseline who did not receive the
recommendation, may be related to usual practices in
Norway of routinely recommending a daily intake of
10 μg vitamin D as part of antenatal care [21]. No
Table 3 Linear regression analysis with vitamin D [25(OH)D] at inclusion and gestational week 28 as dependant variables
At inclusion At gestational week 28
Univariate analysis Multiple analysis Univariate analysis Multiple analysis
n = 735, R2 adj. = 0.46 n = 730, R2 adj. = 0.24
Independent variable R2 adj. B 95 % CI B 95 % CI R2 adj. B 95 % CI B 95 % CI




≥15 −0.56 −4.4 3.3 −6.4 −10 −2.3 ** −4.6 −8.3 −0.92 *
Age at inclusion 0.03 0.94 0.55 1.3 ** 0.14 −0.21 0.49 0.03 1.1 0.64 1.5 ** 0.70 0.26 1.1 **
Parity (para 0 ref) 0.02 0.01
Para1 −1.2 −5.4 3.1 0.24 −3.1 3.6 −2.8 −7.4 1.8 −4.4 −8.7 −0.22 *




South Asia −37 −40 −33 ** −28 −33 −23 ** −26 −31 −21 ** −17 −23 −11 **
Middle East −34 −39 −30 ** −24 −29 −18 ** −21 −26 −15 ** −9.5 −16 −2.9 **
Sub-Saharan Africa −31 −37 −25 ** −20 −27 −13 ** −26 −34 −19 ** −12 −20 −3.1 **
East Asia −17 −24 −10 ** −11 −18 −3.9 ** −19 −28 −11 ** −11 −20 −1.6 *
Other −13 −19 −6.4 ** −7.6 −14 −0.90 * −9.0 −17 −1.3 * −1.4 −9.6 6.9
Season (Summer ref) 0.03 0.01
Winter −9.9 −14 −6.1 ** −5.2 −8.9 −1.4 ** −5.7 −9.8 −1.6 ** −1.3 −6.1 3.4
Geographic
region*Seasona
−11 −16 −4.8 ** −15 −22 −7.4 **
Education level (>12 y ref) 0.11 0.08
10-12 year −14 −18 −10 ** −3.7 −7.1 −0.30 * −11 −15 −6.8 ** −1.8 −6.1 2.5








≥25 kg/m2 −0.76 −4.7 3.2 −0.11 −4.4 4.2
aThe effect of season on 25(OH)D differed by ethnicity: the interaction term is "1" for records with both non-Western and winter and "0" for Western and summer (ref)
bIntake of ≥10 μg vitamin D daily past two weeks
Bold numbers indicate p < 0.05 (*p < 0.05, ** p < 0.01)
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similar increase was observed among ethnic minority
women with a slight deficiency, probably indicating in-
adequate delivery of the message or less compliance in
these groups. Compared with no change or a small in-
crease in 25(OH)D concentrations in women with ad-
equate levels or mild vitamin D deficiency, this
differential change may indicate a beneficial effect of the
recommendations. However, it should be noted that se-
vere vitamin D deficiency was still found in 15-20 % of
the high risk groups. Although the results must be inter-
preted with caution because we did not conduct a ran-
domized controlled trial, the observed increase in
25(OH)D levels in our study is unlikely to be attributable
to physiological changes during pregnancy or regression
to the mean only. Supplementation with a higher dose
of vitamin D than 20 μg or 30 μg would likely be suffi-
cient to achieve acceptable 25(OH)D concentration in
pregnancy.
Conclusion
We found that vitamin D deficiency was prevalent
among South Asian, Middle Eastern and African women
in early pregnancy. Ethnic minority background, low in-
take of supplements, low education and winter season
were independent risk factors for vitamin D deficiency.
After identifying participants with low 25(OH)D
values at study inclusion, and recommending treat-
ment with daily moderate doses of vitamin D, the
daily intake of supplements significantly increased and
the prevalence of severe vitamin D deficiency was
substantially reduced. This cost-effective, and easy-to-
administer recommendation likely contributed the
most to the improved vitamin D status later in preg-
nancy for these women.
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